Document is current
Any future updates will be listed below
-
Authors
Smyth, Matthew J.
Dolinger, Michael T.
Kellar, Amelia
Spencer, Elizabeth A.
Dubinsky, Marla C.
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 9 June 2025
First Online: 6 July 2025
Declarations
:
: Matthew J. Smyth: Consulting fees from Celltrion, Satisfai Health; Michael T. Dolinger: Consulting fees from Neurologica Corp., a subsidiary of Samsung Electronics Co., Ltd., Pfizer, and BMS; Amelia Kellar: Nothing to disclose; Elizabeth A. Spencer: Consulting fees from Prometheus Biosciences; Marla C. Dubinsky: Consulting fees from Abbvie, Abivax, Arena Pharmaceuticals, AstraZeneca, BMS, Boehringer Ingelheim, Celltrion, Celgene, Genentech, Gilead, Janssen, Johnson and Johnson, Merck, Pfizer, Prometheus Biosciences, Prometheus Labs, Spyre, Takeda, Target PharmaSolutions.
